However, synoviocytes from RA patients were implied to produce higher levels of PTX3 in vitro while inhibited by transforming growth factor-beta (TGF-β) and interferon-gamma (IFN-γ) 63. The gene discussed is PTX3; the disease is rheumatoid arthritis.